XML 27 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:    
Research and development $ 8,479,031 $ 3,054,025
General and administrative 6,058,190 3,586,196
Total operating expenses 14,537,221 6,640,221
Operating loss (14,537,221) (6,640,221)
Other income (expense):    
Change in fair value of derivative liability   (26,500)
Interest income, net 13,335 47,225
Grant income 36,754 1,157,449
Total other income (expense) 50,089 1,178,174
Loss before income taxes (14,487,132) (5,462,047)
Net loss $ (14,487,132) $ (5,462,047)
Basic loss per common share $ (1.90) $ (0.87)
Diluted loss per common share $ (1.90) $ (0.87)
Weighted average number of common shares outstanding, basic 7,626,278 6,308,961
Weighted average number of common shares outstanding, diluted 7,626,278 6,308,961